{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T05:04:45Z","timestamp":1789275885918,"version":"build-2803163510"},"reference-count":37,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"crossref","award":["K08AR081391"],"award-info":[{"award-number":["K08AR081391"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"award":["K08AR081391"],"award-info":[{"award-number":["K08AR081391"]}],"id":[{"id":"https:\/\/ror.org\/006zn3t30","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Cachexia is a multifactorial muscle wasting syndrome driven by inflammation, causing increased catabolism and decreased food intake. Using appetite stimulation as part of multidisciplinary rehabilitation for cachexia is an emerging strategy. Olanzapine was originally developed as an atypical antipsychotic and has since emerged in rehabilitative strategies in patients with brain injury and chemotherapy-induced nausea. In 2023, the American Society of Clinical Oncology (ASCO) issued a rapid recommendation for the use of low-dose (2.5\u20135 mg) olanzapine to improve appetite and weight in adults with advanced cancer cachexia, based on novel evidence of increased appetite and weight gain. Methods: We retrospectively evaluated the impact of olanzapine on a real-world cohort of 45 patients with appetite concerns undergoing cancer-related rehabilitation. Patients were retrospectively evaluated for changes in body composition metrics and physical therapy (PT) related outcomes. Results: While treatment groups were well matched at baseline, there were no statistical differences between group outcomes, including weight gain, contrary to findings in other populations. However, fatigue was a significant predictor of PT goal completion across the cohort (p = 0.017), highlighting the need for future studies to investigate this relationship more deeply. Conclusions: These results indicate that the effects of olanzapine may vary between different clinical populations and suggest that further investigation into adjuvant therapies remains critical for optimizing care for cancer patients with anorexia.<\/jats:p>","DOI":"10.3390\/cancers18182943","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:17:42Z","timestamp":1789114662000},"page":"2943","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Analysis of Olanzapine and Functional Outcomes in Outpatient Cancer Rehabilitation"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9453-3882","authenticated-orcid":false,"given":"Ioanna","family":"Karras","sequence":"first","affiliation":[{"name":"Shirley Ryan AbilityLab, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0502-9301","authenticated-orcid":false,"given":"Kayla","family":"Beck","sequence":"additional","affiliation":[{"name":"Shirley Ryan AbilityLab, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addison","family":"Barber","sequence":"additional","affiliation":[{"name":"Shirley Ryan AbilityLab, Chicago, IL 60611, USA"},{"name":"Edward Hines Jr. Veterans Administration Hospital, Maywood, IL 60141, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Abplanalp","sequence":"additional","affiliation":[{"name":"Shirley Ryan AbilityLab, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9109-0421","authenticated-orcid":false,"given":"Ishan","family":"Roy","sequence":"additional","affiliation":[{"name":"Shirley Ryan AbilityLab, Chicago, IL 60611, USA"},{"name":"Department of Physical Medicine and Rehabilitation, Northwestern University, Chicago, IL 60208, USA"},{"name":"Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jcsm.12167","article-title":"Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: Facts and numbers update 2016","volume":"7","author":"Anker","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"189208","DOI":"10.1016\/j.bbcan.2024.189208","article-title":"Mechanisms of cancer cachexia and targeted therapeutic strategies","volume":"1879","author":"Li","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: Links with sarcopenia, anorexia and asthenia","volume":"11","author":"Santos","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4103\/apjon.apjon-2135","article-title":"Relationship of Cachexia with Self-Care Agency and Quality of Life in Cancer Patients: The Case of Turkey","volume":"8","author":"Demirag","year":"2021","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mariean, C.R., Tiuca, O.M., Mariean, A., and Cotoi, O.S. (2023). Cancer Cachexia: New Insights and Future Directions. Cancers, 15.","DOI":"10.3390\/cancers15235590"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","article-title":"Cachexia: A systemic consequence of progressive, unresolved disease","volume":"186","author":"Ferrer","year":"2023","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1200\/JCO.23.01280","article-title":"Cancer Cachexia: ASCO Guideline Rapid Recommendation Update","volume":"41","author":"Roeland","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004850-199511000-00005","article-title":"First clinical experience with olanzapine (LY 170053): Results of an open-label safety and dose-ranging study in patients with schizophrenia","volume":"10","author":"Baldwin","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1172\/JCI93362","article-title":"The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C","volume":"127","author":"Lord","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1639-8","article-title":"Olanzapine-induced weight gain in the rat: Role of 5-HT2C and histamine H1 receptors","volume":"207","author":"Kirk","year":"2009","journal-title":"Psychopharmacology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00004714-199906000-00014","article-title":"Olanzapine: Weight gain and therapeutic efficacy","volume":"19","author":"Gupta","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_13","first-page":"2649","article-title":"Olanzapine for cachexia in patients with advanced cancer: An exploratory study of effects on weight and metabolic cytokines","volume":"23","author":"Naing","year":"2015","journal-title":"Support Care Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/neu.2022.0139","article-title":"Use of Olanzapine to Treat Agitation in Traumatic Brain Injury: A Series of N-of-One Trials","volume":"40","author":"Phyland","year":"2023","journal-title":"J. Neurotrauma"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of Cancer Cachexia: ASCO Guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.22.01997","article-title":"Randomized Double-Blind Placebo-Controlled Study of Olanzapine for Chemotherapy-Related Anorexia in Patients with Locally Advanced or Metastatic Gastric, Hepatopancreaticobiliary, and Lung Cancer","volume":"41","author":"Sandhya","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.6004\/jnccn.2025.7033","article-title":"Olanzapine for Anorexia in Patients with Incurable Cancer and Cachexia (OlAnCa): A Double-Blind, Placebo-Controlled, Randomized Clinical Trial","volume":"23","author":"Othman","year":"2025","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00228-024-03770-x","article-title":"Effects of olanzapine in the improvement of body weight and appetite in patients with cancer or receiving chemotherapy: A systematic review and meta-analysis","volume":"81","author":"Yuan","year":"2025","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.smhs.2025.01.002","article-title":"The role of resistance training in mitigating cancer-induced cachexia: A systematic review","volume":"7","author":"Horawski","year":"2025","journal-title":"Sports Med. Health Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Tsitkanou, S., Murach, K.A., Washington, T.A., and Greene, N.P. (2022). Exercise Counteracts the Deleterious Effects of Cancer Cachexia. Cancers, 14.","DOI":"10.3390\/cancers14102512"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.smhs.2020.11.004","article-title":"Exercise as a therapy for cancer-induced muscle wasting","volume":"2","author":"Halle","year":"2020","journal-title":"Sports Med. Health Sci."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bilski, J., Szlachcic, A., Ptak-Belowska, A., and Brzozowski, T. (2025). Physical Activity, Exerkines, and Their Role in Cancer Cachexia. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26168011"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Allan, J., Buss, L.A., Draper, N., and Currie, M.J. (2022). Exercise in People with Cancer: A Spotlight on Energy Regulation and Cachexia. Front Physiol., 13.","DOI":"10.3389\/fphys.2022.836804"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Hardt, L.M., Herrmann, H.J., Reljic, D., Jaensch, P., Zerth, J., Neurath, M.F., and Zopf, Y. (2023). Are Guideline Recommendations on Supportive Nutrition and Exercise Therapy for Cancer Patients Implemented in Clinical Routine? A National Survey with Real-Life Data. Nutrients, 15.","DOI":"10.3390\/nu15143172"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5535\/arm.22036","article-title":"Rehabilitation of Individuals with Cancer","volume":"46","author":"Mayer","year":"2022","journal-title":"Ann. Rehabil. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100290","DOI":"10.1016\/j.apjon.2023.100290","article-title":"Holistic multimodal care for patients with cancer cachexia and their family caregivers","volume":"10","author":"Amano","year":"2023","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/bmjspcare-2017-001382","article-title":"A multidisciplinary rehabilitation programme for cancer cachexia improves quality of life","volume":"7","author":"Parmar","year":"2017","journal-title":"BMJ Support Palliat. Care"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Del Fabbro, E., and Pandey, S. (2026). The Role of New Agents and Supportive Care in a Multimodal Approach to Cancer Cachexia. Cancers, 18.","DOI":"10.3390\/cancers18040649"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/PHM.0000000000002817","article-title":"Cancer Cachexia Rehabilitation in a Novel Outpatient Clinical Program","volume":"104","author":"Dong","year":"2025","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s11912-022-01258-4","article-title":"Assessment of Cancer-Associated Cachexia\u2014How to Approach Physical Function Evaluation","volume":"24","author":"Fram","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.annonc.2020.02.016","article-title":"ESMO Guidelines Committee. Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment","volume":"31","author":"Fabi","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","article-title":"Cancer-related fatigue\u2014mechanisms, risk factors, and treatments","volume":"11","author":"Bower","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.REO.0000000000000354","article-title":"Cancer-related fatigue is associated with objective measures of physical function before and after a clinical exercise program: A retrospective analysis","volume":"42","author":"Marker","year":"2024","journal-title":"Rehabil. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1574886314666190301152734","article-title":"Positive and Negative Effects of Antipsychotic Medication: An International Online Survey of 832 Recipients","volume":"14","author":"Read","year":"2019","journal-title":"Curr. Drug Saf."},{"key":"ref_36","first-page":"3","article-title":"Atypical antipsychotics: Sleep, sedation, and efficacy","volume":"6","author":"Miller","year":"2004","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Fan, X., Xia, Y., Wu, J., Jia, S., and Hu, J. (2025). Influencing factors related to stroke patients\u2019 rehabilitation motivation: A scoping review. Front Neurol., 16.","DOI":"10.3389\/fneur.2025.1615905"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/2943\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:13:49Z","timestamp":1789272829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/2943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":37,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18182943"],"URL":"https:\/\/doi.org\/10.3390\/cancers18182943","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}